Spoonbill Pushes FDA for 4'-PPT in Special Medical Diets
Published Date: 7/29/2025
Proposed Rule
Summary
The Spoonbill Foundation asked the FDA to approve a new nutrient called 4'-phosphopantetheine (4'-PPT) for use in medical foods. If approved, this change will help people who rely on special medical diets get safer, better nutrition. The FDA is now reviewing the petition, and any updates could affect medical food makers and patients soon.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
FDA Reviewing 4'-PPT for Medical Foods
The FDA has filed a petition to allow 4'-phosphopantetheine (4'-PPT) to be used as a nutrient in medical foods. If approved, this could help people who rely on special medical diets get safer, better nutrition.
Potential Impact on Medical Food Makers
The petition proposes amending food additive rules to permit 4'-PPT in medical foods, which could change what medical food makers are allowed to use. The FDA review and any future regulatory update could affect medical food manufacturers.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in